Comparison between recombinant P450s and human liver microsomes in the determination of cytochrome P450 Michaelis–Menten constants

References

• Baarnhielm C, Backman A, Hoffmann KJ, Weidolf L. (1986). Biotransformation of felodipine in liver microsomes from rat, dog, and man. Drug Metab Dispos 14:613–18.
   PubMed Web of Science ®Google Scholar
• Brown HS, Griffin M, Houston JB. (2007). Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance. Drug Metab Dispos 35:293–301.
   PubMed Web of Science ®Google Scholar
• Chen AG, Wing YK, Chiu H, Lee S, Chen CN, Chan K. (1997a). Simultaneous determination of imipramine, desipramine and their 2- and 10-hydroxylated metabolites in human plasma and urine by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 693:153–8.
   PubMedGoogle Scholar
• Chen TL, Kennedy MJ, Anderson LW, Kiraly SB, Black KC, Colvin OM, Grochow LB. (1997b). Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation. Drug Metab Dispos 25:544–51.
   PubMedGoogle Scholar
• de la Torre R, Farre M, Ortuno J, Mas M, Brenneisen R, Roset PN, Segura J, Cami J. (2000). Non-linear pharmacokinetics of MDMA (‘ecstasy’) in humans. Br J Clin Pharmacol 49:104–9.
   Google Scholar
• Hamman MA, Thompson GA, Hall SD. (1997). Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C. Biochem Pharmacol 54:33–41.
   PubMed Web of Science ®Google Scholar
• Hasler JA, Estabrook R, Murray M, Pikuleva I, Waterman M, Capdevila J, Holla V, Helvig C, Falck JR, Farrell G, Kaminsky LS, Spivack SD, Boitier E, Beaune P. (1999). Human cytochromes P450. Mol Aspect Med 20:1–137.
   Google Scholar
• Hidalgo M, Villalona-Calero MA, Eckhardt SG, Drengler RL, Rodriguez G, Hammond LA, Diab SG, Weiss G, Garner AM, Campbell E, Davidson K, Louie A, O’Neil JD, von Borstel R, Von Hoff DD, Rowinsky EK. (2000). Phase I and pharmacologic study of PN401 and fluorouracil in patients with advanced solid malignancies. J Clin Oncol 18:167–77.
   PubMed Web of Science ®Google Scholar
• Hutzler JM, Frye RF, Korzekwa KR, Branch RA, Huang SM, Tracy TS. (2001). Minimal in vivo activation of CYP2C9-mediated flurbiprofen metabolism by dapsone. Eur J Pharm Sci 14:47–52.
   PubMed Web of Science ®Google Scholar
• Isoherranen N, Kunze KL, Allen KE, Nelson WL, Thummel KE. (2004). Role of itraconazole metabolites in CYP3A4 inhibition. Drug Metab Dispos 32:1121–31.
   PubMed Web of Science ®Google Scholar
• Jones HM, Houston JB. (2004). Substrate-depletion approach for determining in vitro metabolic clearance: time dependencies in hepatocyte and microsomal incubations. Drug Metab Dispos 32:973–82.
   PubMed Web of Science ®Google Scholar
• Kaul S, Shukla UA, Barbhaiya RH. (1995). Nonlinear pharmacokinetics of nefazodone after escalating single and multiple oral doses. J Clin Pharmacol 35:830–9.
   PubMed Web of Science ®Google Scholar
• Kirchheiner J, Meineke I, Steinbach N, Meisel C, Roots I, Brockmoller J. (2003). Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humans. Br J Clin Pharmacol 55:51–61.
   PubMed Web of Science ®Google Scholar
• Komura H, Kawase A, Iwaki M. (2005). Application of substrate depletion assay for early prediction of nonlinear pharmacokinetics in drug discovery: assessment of nonlinearity of metoprolol, timolol, and propranolol. J Pharm Sci 94:2656–66.
   PubMed Web of Science ®Google Scholar
• Kramer MA, Tracy TS. (2008). Studying cytochrome P450 kinetics in drug metabolism. Expert Opin Drug Metab Toxicol 4:591–603.
   PubMed Web of Science ®Google Scholar
• Laine R. (2008). Metabolic stability: main enzymes involved and best tools to assess it. Curr Drug Metab 9:921–7.
   PubMed Web of Science ®Google Scholar
• Ludwig E, Wolfinger H, Ebner T. (1998). Assessment of microsomal tolbutamide hydroxylation by a simple thin-layer chromatography radioactivity assay. J Chromatogr B Biomed Sci Appl 707:347–50.
   PubMedGoogle Scholar
• Masubuchi Y, Hosokawa S, Horie T, Suzuki T, Ohmori S, Kitada M, Narimatsu S. (1994). Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase. Drug Metab Dispos 22:909–15.
   PubMed Web of Science ®Google Scholar
• Nath A, Atkins WM. (2006). A theoretical validation of the substrate-depletion approach to determining kinetic parameters. Drug Metab Dispos 34:1433–5.
   PubMed Web of Science ®Google Scholar
• Obach RS. (2001). The prediction of human clearance from hepatic microsomal metabolism data. Curr Opin Drug Discov Devel 4:36–44.
   PubMedGoogle Scholar
• Obach RS, Reed-Hagen AE. (2002). Measurement of Michaelis constants for cytochrome P450-mediated biotransformation reactions using a substrate-depletion approach. Drug Metab Dispos 30:831–7.
   PubMed Web of Science ®Google Scholar
• Patki KC, Von Moltke LL, Greenblatt DJ. (2003). In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5. Drug Metab Dispos 31:938–44.
   PubMed Web of Science ®Google Scholar
• Rowland A, Elliot DJ, Knights KM, Mackenzie PI, Miners JO. (2008). The ‘albumin effect’ and in vitro–in vivo extrapolation: sequestration of long-chain unsaturated fatty acids enhances phenytoin hydroxylation by human liver microsomal and recombinant cytochrome P450 2C9. Drug Metab Dispos 36:870–7.
   PubMed Web of Science ®Google Scholar
• Sjögren E, Lennernas H, Andersson TB, Grasjo J, Bredberg U. (2009). The multiple depletion curves method provides accurate estimates of intrinsic clearance (CLint), maximum velocity of the metabolic reaction (Vmax), and Michaelis constant (Km): accuracy and robustness evaluated through experimental data and Monte Carlo simulations. Drug Metab Dispos 37:47–58.
   PubMed Web of Science ®Google Scholar
• Spigset O, Granberg K, Hagg S, Soderstrom E, Dahlqvist R. (1998). Non-linear fluvoxamine disposition. Br J Clin Pharmacol 45:257–63.
   PubMed Web of Science ®Google Scholar
• Tang C, Lin Y, Rodrigues AD, Lin JH. (2002). Effect of albumin on phenytoin and tolbutamide metabolism in human liver microsomes: an impact more than protein binding. Drug Metab Dispos 30:648–54.
   PubMed Web of Science ®Google Scholar
• Tang-Liu DD, Williams RL, Riegelman S. (1982). Nonlinear theophylline elimination. Clin Pharmacol Ther 31:358–69.
   PubMed Web of Science ®Google Scholar
• Walsky RL, Obach RS. (2004). Validated assays for human cytochrome P450 activities. Drug Metab Dispos 32:647–60.
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Guo Z, Persmark M, Mimura M, Inoue K, Guengerich FP, Shimada T. (1994). Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes. Mol Pharmacol 46:568–77.
   PubMed Web of Science ®Google Scholar
• Yeh KC, Stone JA, Carides AD, Rolan P, Woolf E, Ju WD. (1999). Simultaneous investigation of indinavir nonlinear pharmacokinetics and bioavailability in healthy volunteers using stable isotope labeling technique: study design and model-independent data analysis. J Pharm Sci 88:568–73.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Matsumoto S, Ding LR, Fischer NE, Inaba T. (2004). The comparative interaction of human and bovine serum albumins with CYP2C9 in human liver microsomes. Life Sci 75:2145–55.
   PubMed Web of Science ®Google Scholar